Glenn Whaley
CIK: 0001724623
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
IMMUNIC, INC.
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Jun 29, 2026IMUX
IMMUNIC, INC.
Award(A)DirectStock Option
120K shares- - Jul 16, 2025IMUX
IMMUNIC, INC.
Award(A)DirectStock Appreciation Right
280K shares- - Jul 16, 2025IMUX
IMMUNIC, INC.
Award(A)DirectStock Appreciation Right
560K shares- - Jul 16, 2025IMUX
IMMUNIC, INC.
Award(A)DirectStock Appreciation Right
560K shares- - Jul 16, 2025IMUX
IMMUNIC, INC.
Award(A)DirectStock Appreciation Right
280K shares- - Jul 16, 2025IMUX
IMMUNIC, INC.
Award(A)DirectStock Appreciation Right
280K shares- - Jun 5, 2025IMUX
IMMUNIC, INC.
Award(A)DirectStock Option
503.5K shares- - Jun 5, 2025IMUX
IMMUNIC, INC.
Award(A)DirectStock Option
503K shares- - Jun 3, 2025IMUX
IMMUNIC, INC.
Purchase(P)Direct45K shares at avg. $0.71$32K - May 30, 2025IMUX
IMMUNIC, INC.
Award(A)Direct25K shares at avg. $0.56$14K - Dec 4, 2024IMUX
IMMUNIC, INC.
Award(A)DirectStock Option
265K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 29, 2026 | IMUX IMMUNIC, INC. | Award(A) Stock Option | 120,000 | - | - | Direct |
| Jul 16, 2025 | IMUX IMMUNIC, INC. | Award(A) Stock Appreciation Right | 280,000 | - | - | Direct |
| Jul 16, 2025 | IMUX IMMUNIC, INC. | Award(A) Stock Appreciation Right | 560,000 | - | - | Direct |
| Jul 16, 2025 | IMUX IMMUNIC, INC. | Award(A) Stock Appreciation Right | 560,000 | - | - | Direct |
| Jul 16, 2025 | IMUX IMMUNIC, INC. | Award(A) Stock Appreciation Right | 280,000 | - | - | Direct |
| Jul 16, 2025 | IMUX IMMUNIC, INC. | Award(A) Stock Appreciation Right | 280,000 | - | - | Direct |
| Jun 5, 2025 | IMUX IMMUNIC, INC. | Award(A) Stock Option | 503,500 | - | - | Direct |
| Jun 5, 2025 | IMUX IMMUNIC, INC. | Award(A) Stock Option | 503,000 | - | - | Direct |
| Jun 3, 2025 | IMUX IMMUNIC, INC. | Purchase(P) | 45,000 | $0.71 | $32,076 | Direct |
| May 30, 2025 | IMUX IMMUNIC, INC. | Award(A) | 25,000 | $0.56 | $14,000 | Direct |
| Dec 4, 2024 | IMUX IMMUNIC, INC. | Award(A) Stock Option | 265,000 | - | - | Direct |
1-11 of 11 transactions
About Whaley Glenn
Whaley Glenn (SEC CIK 0001724623) files insider reports with the SEC as Chief Financial Officer of IMMUNIC, INC. (IMUX).
Signal8 holds 6 ownership filings by Whaley Glenn, all Form 4s, filed between Dec 6, 2024 and Jun 29, 2026. Those filings report 11 transactions, from Dec 4, 2024 to Jun 29, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Whaley Glenn's filings is in NEW YORK, NY.
Recent filings by Whaley Glenn
- Jun 29, 2026: Grant or award of IMUX derivative securities (Form 4, code A).
- Jul 16, 2025: Grants or awards of IMUX derivative securities (5 lines, Form 4, code A).
- Jun 5, 2025: Grants or awards of IMUX derivative securities (2 lines, Form 4, code A).
- Jun 3, 2025: Open-market purchase of IMUX shares (Form 4, code P).
- May 30, 2025: Grant or award of IMUX shares (Form 4, code A).
Other insiders filing for IMMUNIC, INC. (IMUX)
- Nagel Robert Thorvald, Director
- BVF PARTNERS L P/IL, Director
- Ridloff Elena, Director
- Skerjanec Simona, Director
- Rudick Richard Alan, Director
- PHILLIPS BARCLAY A, Director